Novartis launches ‘Sjöut for Sjögren’s’ campaign, teams with Carrie Ann Inaba

Novartis has initiated a new disease awareness campaign focused on Sjögren’s syndrome, enlisting the support of prominent dancer and TV personality Carrie Ann Inaba. This strategic partnership aims to elevate the visibility of Sjögren’s syndrome, a chronic autoimmune condition that often goes undiagnosed, impacting millions worldwide.

The campaign, titled ‘Sjöut for Sjögren’s,’ seeks to educate both patients and healthcare professionals about the symptoms and challenges associated with the disease. By leveraging Inaba’s celebrity status, Novartis aims to foster greater understanding and dialogue around Sjögren’s syndrome, which is often overshadowed by other autoimmune disorders.

This initiative underscores the growing trend within the pharmaceutical industry to engage public figures in disease awareness efforts. As awareness increases, it may lead to improved diagnosis rates and treatment options, ultimately benefiting patients and healthcare systems alike.